Company
genedrive PLC
LON:GDR
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
240 stories · page 1 of 3
Genedrive slumps on higher full year losses
Revenue in the 12 months to 30 June fell to £50,000 from £690,000 a year prior
Genedrive shares soar 25% on US FDA talks
The company is seeking regulatory approval in the US for its Genedrive MT-RNR1 ID kit
Genedrive gets UK coronavirus test device approval
The company’s kit is a rapid molecular diagnostic test that delivers positive results as quickly as seven-and-a-half minutes and negative results within 17 minutes
genedrive readies system for antibiotic-induced hearing loss launch
The group is seeking CE mark clearance for the new Genedrive system in the coming weeks and prior to the commercial launch of the assay, investors were told
Genedrive overcomes technical hurdles with COVID-19 diagnostic kit
The company has overcome significant obstacles in the development of the kit, which it believes will be superior to competing products
genedrive soars as it confirms receipt of Indian import licence for COVID-19 test
The licence follows approval of the test by the Indian Centre for Medical Research on April 30
genedrive COVID-19 PCR test approved by the Indian regulator
The plan is to begin “commercial activities” through its existing local distributor Divoc Health, the company said
Genedrive says HCV test passes independent real-world study with flying colours
The study yielded sensitivity specifications of 96.2-100% and specificity specifications of 98.7-99.5%
Genedrive’s inclusion in a Public Health England framework pact positive for future revenues, says broker
The framework allows Public Health England to issue call-off orders for products and services up to a combined £3bn
Genedrive included in a Public Health England framework agreement for diagnostic equipment and services
All of the company’s three CE-marked products fall within the framework agreement, investors were told
genedrive included in a Public Health England framework agreement for diagnostic equipment and services
All of the company’s three CE-marked products fall within the framework agreement, investors were told
Genedrive optimistic about second half of financial year as it eyes revenue potential from existing contracts
The diagnostics firm is confident in the contract with Beckman Coulter Life Sciences and the ongoing opportunity with a European Ministry of Health
Hardware & electrical equipment
genedrive inks deal with US military contractor for pathogen test
The tie-up with Mountain Horse Solutions helps overcome the “challenging and time consuming” process of contracting with the American government, the company said
genedrive says new guidance bodes well for assay that helps prevent antibiotic hearing loss in babies
The updated advice follows work carried out by researchers Manchester University NHS Foundation Trust and Liverpool Women's Hospital using the company’s assay designed specifically to detect AHL
Proactive news headlines: Genedrive, Open Orphan, Ceres Power Holdings, DeepVerge...
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive ships first COVID-19 PCR kits to the US ahead of sales ramp-up by partner
The 96 SARS-CoV-2 technology is said to be ideally suited for use on Beckman Coulter’s high throughput robotic Biomek i7 instrument
Genedrive close to hitting the market with coronavirus tests
Here we take a closer look at Genedrive PLC (LON:GDR)
Archive
Hunters Property slides as it accepts lowball offer
A look at some of the major movers in London on Thursday
genedrive and Beckman Coulter take relationship to the "next stage" as pair target US and Europe with coronavirus testing technology
The agreement allows the American biomedical company to sell and distribute genedrive's COVID-19 PCR test
Genedrive says diagnostic kit can detect new COVID-19 strain
The kit is designed to target both the E and N genes of SARS-CoV-2, said Genedrive.
Genedrive soars as it outlines US plans for 96 SARS-CoV-2 kit
The company has told the US Food & Drug Administration that it intends to import and distribute the product prior to emergency use authorisation
genedrive completes antibiotic induced hearing loss study; results due next year
The company said it was now working with the study team as well as commercial partner, Inspiration Healthcare, ahead of the commercial roll-out
Genedrive CEO hails 'excellent' result from hepatitis-C study in India, a key target market
The work was carried out by Dr Ekta Gupta at the Institute of Liver and Biliary Sciences, New Delhi
genedrive chairman says sales orders include "a potential supply contract to a ministry of health of a European country"
"If converted to a sale this would be for low double-digit millions of pounds of revenue and delivered in the first quarter of the new calendar year without the need for prolonged regulatory approvals," added Dr Ian Gilham
genedrive PLC unveils 15-minute COVID-19 point-of-care test direct from saliva
The simplicity and speed of the test mean results can be delivered while the patient waits, rather than material having to be shipped and then assessed, which takes at least 24 hours
Genedrive's COVID-19 test kit approved for sale in South Africa
“South Africa is a key territory for our distributors and this approval will now provide an acceleration of commercial sales activity in the area,” said CEO David Budd
genedrive testing kit verified to work with Beckman Coulter extraction process
Initial testing took place using Beckman Coulter Life Sciences' chemistry on respiratory swabs in conjunction with gendrive’s 96 SARS-CoV-2 equipment
Archive
FTSE 100 closes ahead with Ocado top of the pile after successful M&S switch
Britain's benchmark of leading shares finished the day up around 79 points, or 1.32%, to 6,105
Are small-cap biotech stocks good investments now?
We look at the sector's success stories and assess what we can expect in the coming months
Genedrive surges as it announces coronavirus testing collaboration
"The integration of Beckman Coulter Life Sciences' and genedrive's technologies produces a formidable workhorse solution," said Beckman Coulter’s Greg Milosevich.
Coronavirus test makers could be about to cash in as US heads for winter crunch
Laboratory operators in the US have said a lack of capacity has created a backlog of tests that are being processed too slowly to stem the tide of infections
Genedrive announces new software tool for its Genedrive 96 SARS-CoV-2 kit
"We remain encouraged by the interest in our Genedrive 96-SARS-CoV-2 test,” said CEO David Budd
Genedrive moves to cash position as bondholder converts loan
Following completion, Genedrive will have gross cash balances of £8.6mln and debt of £2.6mln
Genedrive makes life easier for coronavirus testing labs
The diagnostics firm has been rocketing thanks to its efficient coronavirus tests, but it is also focusing on a baby deafness assay
Coronavirus pandemic gives AIM's healthcare sector a new outlook
Healthcare firms have raised £390mln in the four months to April
Archive
Small Cap Wrap- Tissue Regenix; genedrive: Tekcapital and more...
Breakfast Buffet Synectics 120p £21.3m (SNX.) Two new multi-year contracts with existing long-term customers.
Genedrive coronavirus test capable of generating £1.5mln of revenue per week, says broker
The molecular diagnostics company's new test can support high-volume coronavirus testing for governments
Proactive news headlines: Genedrive, OPG Power Ventures, Tiziana Life Sciences, One Media IP ...
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive's shares surge as coronavirus (COVID-19) testing kit gets CE-IVD mark
Now that CE-IVD marking has been achieved, the company can start across the EU - including the UK - immediately
Resource and travel sectors wield the biggest blades as companies slash capital expenditure
A total of £10.4bn has been slashed from planned capex in the energy sector, with all but £1.4bn of that coming from Shell and BP
UK in talks to buy Roche’s Covid-19 antibody tests following US, EU lead
Roche said it has capacity to deliver hundreds of thousands of the tests per week to the UK
genedrive raises £1mln in oversubscribed broker option to placing
The broker option forms part of the fundraising announced last week to support the rapid development of the company's coronavirus tests
genedrive hepatitis-C diagnostic joins list of WHO pre-qualified devices; launches £8mln fund-raising
The move means the product joins a list of devices eligible for purchase by United Nations procurement agencies, with World Health Organisation member states encouraged to buy from the list
Archive
Proactive news headlines: Genedrive, i3 Energy, Tekcapital, Vectura Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive surges as coronavirus test kit passes critical development milestones
The diagnostics firm is now aiming for the test to receive CE marking in around three weeks
Genedrive and Inspiration Healthcare to distribute neonatal hearing loss test in UK & Ireland
The Genedrive test screens newborns for a genetic mutation called mt-RNR1 that can cause lifelong and irreversible deafness to a child upon administration of certain antibiotics
Archive
Proactive news snapshot: Genedrive, Feedback, Power Metal Resources, Gfinity, Tissue Regenix…
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive shares jump as it aims to have a coronavirus test available within five weeks
Genedrive and Cytiva (formerly GE Healthcare Life Science) will jointly develop the Genedrive 96 SARS-CoV-2 assay for use on lab-based PCR instruments.
Genedrive CEO targets ‘fastest route to market’ for out-of-hospital coronavirus test
The company's test for coronavirus is designed to deliver a result quickly in close proximity to patients, rather than needing to send samples to labs for a conclusive result
Firms across the coronavirus treatment chain see share prices surge
Companies involved in diagnostics, drug development and medical equipment provision have all seen strong stock price rises as the world grapples with the pandemic
Archive
Proactive news snapshot: Genedrive, Silence Therapeutics, Gfinity, SIMEC Atlantis Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Bagir shabbier as coronavirus forces factory closures
A look at some of the major risers and fallers in London on Wednesday
Genedrive rockets as it says coronavirus test could be available in eight weeks
The diagnostics firm is also working on a second product that will allow coronavirus testing outside of hospitals in places such as clinics and ICUs
Genedrive frustrated by slow take-up of diagnostic kit
The kit performed exceptionally well in the field as demonstrated in HCV study data and AIHL CE marking studies’.
Archive
Proactive news snapshot: Rockfire Resources, Genedrive, Collagen Solutions, Power Metal Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive gains as it reports high clinical accuracy for infant hearing loss test
The kit is designed to screen babies for a genetic mutation, MT-RNR1, which if present, can cause lifelong deafness if they are prescribed with the antibiotic gentamicin
Genedrive gets CE mark for baby deafness diagnostic test
David Budd, genedrive’s chief executive, said: "CE marking of our RNR1 test allows for the next phase, with implementation evaluation by our NHS partners in Manchester and Liverpool."
Genedrive gets approval to trial baby deafness test in NHS hospitals
Genedrive says its test delivers a genetic result in less than 30 minutes
Genedrive expects to make good progress with diagnostics pipeline
The update was provided alongside full-year results from the group, which has developed rapid assays for Hepatitis-C (HCV) and pathogen detection
Archive
Proactive news snapshot: Kavango Resources, OptiBiotix Health, Cello Health...
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive zips higher as chairman snaps up £10,000 worth of shares
Ian Gilham bought 51,250 shares at 19p apiece on Tuesday
Archive
Proactive news snapshot: ClearStar, Ceres Power, Concepta, IQ-AI …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Begbies Traynor firing on all cylinders
A look at the day's major movers, including Knights Group, CyanConnode, Vela, Primorus, Two Shields, Anglo African Agriculture, Panthera Resources and Elegant Hotels
Genedrive ‘confident’ of WHO approval for hepatitis C test by autumn
There have been some delays to the WHO’s qualification trial owing to a lack of low viral load samples for analysis, but bosses remain confident of approval and expect a result by this autumn
Peel Hunt resumes coverage of Genedrive with a ‘buy’ rating and 60p price target after recent results
The Peel Hunt analysts noted stronger traction than expected with the US Department of Defence (DoD), with the group having received a second order of the DoD in January
Archive
Aukett Swanke subsides after downbeat AGM statement
A look at the day's major movers, including Ironveld, Brave Bison, Pebble Beach, Zanaga, Debenhams, 7digital and Diurnal
Archive
Proactive news snapshot: Europa Metals, Ceres Power, Arix Bioscience, Hurricane Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive optimistic about some near-term progress on its Genedrive HCV ID registrations
"We continue to execute our strategy of market entry for our Hepatitis C point of need molecular test and development of both our tuberculosis and antibiotic-induced hearing loss assays," said David Budd, the CEO of genedrive
Archive
Blue chips to swerve Thursday’s Brexit fall-out, small caps will be in spotlight
IGas and Gulf Keystone are on the agenda, meanwhile Brexit will likely be a talking point for Eddie Stobart Logistics.
Archive
Brexit date arrives but March 29 to be a damp squib although parliamentary vote might not be
Aside from the latest instalment of the Brexit saga, the week ahead will bring updates from housebuilder Bellway, tobacco firm Imperial Brands, and soft drinks group Fevertree
Archive
Proactive news snapshot: EQTEC , Itaconix, Mirada …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
CloudCall's new user intake rate accelerates
A look at the day's major movers, including Elegant Hotels, Mears Group, Spire Healthcare, 7digital and Mirada